Is Invivo Therapeutics Holdings Corp (NVIV) Stock Worth a Buy Tuesday?

Tuesday, November 22, 2022 01:23 PM | InvestorsObserver Analysts

Mentioned in this article

Is Invivo Therapeutics Holdings Corp (NVIV) Stock Worth a Buy Tuesday?

Invivo Therapeutics Holdings Corp (NVIV) stock is lower by -81.65% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives NVIV stock a score of 14 out of a possible 100.

That rank is influenced by a long-term technical score of 5. NVIV's rank also includes a short-term technical score of 38.

NVIV has an Overall Score of 14. Find out what this means to you and get the rest of the rankings on NVIV!

See Full NVIV Report

What's Happening with NVIV Stock Today

Invivo Therapeutics Holdings Corp (NVIV) stock has fallen -8.95% while the S&P 500 is higher by 0.95% as of 1:01 PM on Tuesday, Nov 22. NVIV is lower by -$0.23 from the previous closing price of $2.57 on volume of 73,662 shares. Over the past year the S&P 500 has fallen -14.85% while NVIV is lower by -81.65%. NVIV lost -$8.01 per share in the over the last 12 months. Click Here to get the full Stock Report for Invivo Therapeutics Holdings Corp stock.